Prediction of disease progression, treatment response and dropout in chronic obstructive pulmonary disease (COPD).

Musuamba, F T; Teutonico, D; Maas, H J; Facius, A; Yang, S; Danhof, M; Della Pasqua, O

Musuamba, F T; Teutonico, D; Maas, H J; Facius, A; Yang, S; Danhof, M; Della Pasqua, O.

Affiliation

Musuamba FT; Gorlaeus Laboratories, Division of Pharmacology, Leiden Academic Centre for Drug Research, P.O. Box 9502, 2300 RA, Leiden, The Netherlands.

Pharm Res ; 32(2): 617-27, 2015 Feb.

Article in En | MEDLINE | ID: mdl-25231008

Subject(s)

Disease Progression; Patient Dropouts; Pulmonary Disease, Chronic Obstructive/diagnosis; Pulmonary Disease, Chronic Obstructive/therapy; Adult; Aged; Aged, 80 and over; Female; Forced Expiratory Volume/physiology; Humans; Male; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive/epidemiology; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patient Dropouts / Disease Progression / Pulmonary Disease, Chronic Obstructive Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Pharm Res Year: 2015 Document type: Article Affiliation country: Netherlands Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google